Nuvation Bio Stock Forecast

Stock Price Forecast

According to 10 analysts polled by S&P Global, Nuvation Bio stock has a consensus rating of "Strong Buy" and an average price target of $12.33. The average 1-year stock price forecast is 131.33% higher than the current stock price, while the lowest is $7.00 (+31.33%) and the highest is $20 (+275.23%).

Price Target: $12.33 (+131.33%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$7.00	$12.33	$12	$20
Change	+31.33%	+131.33%	+125.14%	+275.23%

Analyst Ratings

The average analyst rating for Nuvation Bio stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Jan '26	Feb '26	Mar '26	Apr '26	May '26	Jun '26
Strong Buy	7	7	7	7	7	7
Buy	2	2	2	2	2	2
Hold	1	1	1	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	10	10	10	10	10	10

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Yaron Werber TD Cowen	TD Cowen	Buy Reiterates n/a	Buy	Reiterates	n/a	n/a	Jun 1, 2026
Robert Burns H.C. Wainwright	H.C. Wainwright	Buy Reiterates $17	Buy	Reiterates	$17	+218.95%	May 26, 2026
Mayank Mamtani B. Riley Securities	B. Riley Securities	Buy Maintains $12	Buy	Maintains	$12	+125.14%	May 21, 2026
David Nierengarten Wedbush	Wedbush	Buy Maintains $11	Buy	Maintains	$11	+106.38%	May 5, 2026
Boris Peaker JonesTrading	JonesTrading	Buy Maintains $10 → $12	Buy	Maintains	$10 → $12	+125.14%	May 5, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

202.59M

from 62.90M

222.07%

from 62.90M

Revenue Next Year

290.27M

from 202.59M

43.28%

from 202.59M

EPS This Year

-0.28

from -0.49

EPS Next Year

-0.06

from -0.28

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	-	-	-	7.87M	62.90M	202.59M
Revenue Growth	-	-	-	-	698.96%	222.07%
Gross Profit	-	-	-	795.00K	53.60M	184.71M
Gross Margin	-	-	-	10.10%	85.22%	91.17%
Operating Income	-89.53M	-119.73M	-99.82M	-167.56M	-213.06M	-127.51M
Net Income	-86.85M	-104.20M	-75.80M	-567.94M	-204.63M	-116.79M
EPS	-	-	-	-	-0.49	-0.28
Free Cash Flow	-39.03M	-62.44M	-41.59M	-52.19M	-115.78M	-87.92M
No. Analysts	-	-	-	-	-	10

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2026	2027	2028
High	215.5M
Avg	202.6M
Low	181.6M

Revenue Growth

Revenue Growth	2026	2027	2028
High	242.6%
Avg	222.1%
Low	188.7%

EPS Forecast

EPS	2026	2027	2028
High	-0.28
Avg	-0.28
Low	-0.28

EPS Growth

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-